Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2005 Oct 1;366(9492):1165-74.
doi: 10.1016/S0140-6736(05)67339-4. Epub 2005 Sep 22.

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

Affiliations
Meta-Analysis

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

T Jefferson et al. Lancet. .

Erratum in

  • Lancet. 2006 Mar 25;367(9515):986

Abstract

Background: Influenza vaccination of elderly individuals is recommended worldwide. Our aim was to review the evidence of efficacy and effectiveness of influenza vaccines in individuals aged 65 years or older.

Methods: We searched five electronic databases to December, 2004, in any language, for randomised (n=5), cohort (n=49), and case-control (n=10) studies, assessing efficacy against influenza (reduction in laboratory-confirmed cases) or effectiveness against influenza-like illness (reduction in symptomatic cases). We expressed vaccine efficacy or effectiveness as a proportion, using the formula VE=1-relative risk (RR) or VE*=1-odds ratio (OR). We analysed the following outcomes: influenza, influenza-like illness, hospital admissions, complications, and deaths.

Findings: In homes for elderly individuals (with good vaccine match and high viral circulation) the effectiveness of vaccines against influenza-like illness was 23% (95% CI 6-36) and non-significant against influenza (RR 1.04, 0.43-2.51). Well matched vaccines prevented pneumonia (VE 46%, 30-58) and hospital admission (VE 45%, 16-64) for and deaths from influenza or pneumonia (VE 42%, 17-59), and reduced all-cause mortality (VE 60%, 23-79). In elderly individuals living in the community, vaccines were not significantly effective against influenza (RR 0.19, 0.02-2.01), influenza-like illness (RR 1.05, 0.58-1.89), or pneumonia (RR 0.88, 0.64-1.20). Well matched vaccines prevented hospital admission for influenza and pneumonia (VE 26%, 12-38) and all-cause mortality (VE 42%, 24-55). After adjustment for confounders, vaccine performance was improved for admissions to hospital for influenza or pneumonia (VE* 27%, 21-33), respiratory diseases (VE* 22%, 15-28), and cardiac disease (VE* 24%, 18-30), and for all-cause mortality (VE* 47%, 39-54).

Interpretation: In long-term care facilities, where vaccination is most effective against complications, the aims of the vaccination campaign are fulfilled, at least in part. However, according to reliable evidence the usefulness of vaccines in the community is modest.

PubMed Disclaimer

Comment in

  • Resistance to anti-influenza agents.
    Guan Y, Chen H. Guan Y, et al. Lancet. 2005 Oct 1;366(9492):1139-40. doi: 10.1016/S0140-6736(05)67340-0. Epub 2005 Sep 22. Lancet. 2005. PMID: 16198748 Free PMC article. No abstract available.
  • Influenza vaccination in elderly people.
    Simonsen L, Viboud C, Taylor R. Simonsen L, et al. Lancet. 2005 Dec 17;366(9503):2086. doi: 10.1016/S0140-6736(05)67884-1. Lancet. 2005. PMID: 16360785 No abstract available.

Publication types

Substances

LinkOut - more resources